Home›Biochemistry›Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
BiochemistryJoVE (Open Access)Citable · DOI
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
DOI: 10.3791/3852-v
What you'll learn
✓Perform rapid quantitative assessment of enoxaparin anticoagulant effect in whole blood
✓Apply heparinase digestion to isolate and measure low-molecular-weight-heparin contribution
✓Operate point-of-care coagulation assay apparatus and interpret results
Protocol
Demonstration of a rapid quantitative assay of the inhibition of blood coagulation by the low-molecular-weight-heparin, enoxaparin. The contribution of enoxaparin is assessed by removing its influence through digestion with heparinase. A fuller description of the assay is detailed in our published paper.1 The assay still requires clinical confirmation.
Difficulty
intermediate
Total time
~15-20 min/sample
Biosafety
BSL-1
Steps
1
Understand enoxaparin efficacy assay principle
Review the fundamentals of measuring low-molecular-weight-heparin inhibition of blood coagulation and the rationale for heparinase-based removal of enoxaparin influence to quantify its contribution.
▶ 00:05
2
Identify assay apparatus and equipment
Familiarize with the point-of-care device and instrumental setup required for rapid quantitative coagulation assessment.
▶ 02:25
3
Digest samples with heparinase enzyme
Prepare whole blood samples and treat with heparinase to selectively degrade enoxaparin, enabling quantification of its anticoagulant effect.
▶ 02:39
4
Load and prepare assay cartridges
Insert processed blood samples into assay cartridges according to manufacturer specifications for point-of-care testing.
▶ 05:25
5
Execute quantitative coagulation assay procedure
Run the complete assay protocol on the point-of-care apparatus, monitoring blood coagulation kinetics with and without heparinase treatment.
▶ 06:21
6
Analyze and interpret assay results
Review quantitative output data to determine enoxaparin efficacy based on differences in coagulation parameters between heparinase-treated and untreated samples.
▶ 09:22
💬 Comments coming soon
New protocols and pitfalls, in your inbox
A short email when we add notable lab videos and failure cases. No spam, unsubscribe anytime.